Lin Qian

Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.

D. Gu, J. Mao, D. Ji, 2015, Cancer letters.

Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation

D. Gu, J. Mao, Hua Zhu, 2016, Scientific Reports.

MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.

Dong-rong Yang, Jundong Zhou, D. Gu, 2015, Biochemical and biophysical research communications.